申请人:Mcconnell Darryl
公开号:US20110118208A1
公开(公告)日:2011-05-19
The present invention encompasses compounds of general formula (1)
wherein
R
1
to R
3
are defined as in claim
1,
which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
本发明涵盖了通式(1)中定义的化合物,其中R1至R3的定义如权利要求书中所述,适用于治疗由过度或异常细胞增殖所特征的疾病,并用于制备具有上述特性的药物。